Filter posts

Greenwood Highlights Role of Innovation in Solving Opioid Crisis

The numbers are staggering. The opioid epidemic is costing our nation more than $500 billion annually in …

Senate Has the Power to Expand Access to Medication for Opioid Addiction

BIO President and CEO Jim Greenwood posted the following op-ed on Linked-In today, making the …

Greenwood comment on PABNAB

BIO and BIO’s Board-level Workforce Development, Diversity and Inclusion (WDDI) Committee were disappointed that the …

Lupus Patients Find Hope In the Face of Hardship

One and a half million and counting. That’s how many people suffer from lupus in …

The Latest Good News on Prescription Drug Costs

Two-hundred biotech allies from more than 40 different states visited Washington D.C. this week. These …

BIO Anniversary Reflections: We’re Saving Lives at 25

This year the Biotechnology Innovation Organization (BIO) celebrates our 25th anniversary. It’s impossible to review …

Celebrating 21st Century Cures One Year Later

Today marks an important day for America. It was just one year ago that the …

Biotech Faces Up to Our Own Leadership Diversity Challenge

Disease is an equal-opportunity enemy. It strikes men and women; children and seniors; and people …

Jim Greenwood Talks Biotech Innovation With Bloomberg Radio

While in Boston this week, BIO CEO Jim Greenwood sat down with Bloomberg Boston Bureau …

Finger Pointing Won’t Solve the Opioid Crisis. Innovation Will

In his column, the New York Times’s Nicholas Kristof’s does a disservice to the millions of …